Abstract:<p>Nanotechnology has revolutionized diverse fields, which include agriculture, the consumer market, medicine, and other fields. Widespread use of nanotechnology-based products has led to increased prevalence of these novel formulations in the environment, which has raised concerns regarding their deleterious effects. The application of nanotechnology-based formulations into clinical use is hampered by the lack of the availability of effective in vitro systems, which could accurately assess their in vivo toxic effects. A plethora of studies has shown the hazardous effects of nanoparticle-based formulations in two-dimensional in vitro cell cultures and animal models. These have some associated disadvantages when used for the evaluation of nano-toxicity. Organoid technology fills the space between existing two-dimensional cell line culture and in vivo models. The uniqueness of organoids over other systems for evaluating toxicity caused by nano-drug formulation includes them being a co-culture of diverse cell types, dynamic flow within them that simulates the actual flow of nanoparticles within biological systems, extensive cell–cell, cell–matrix interactions, and a tissue-like morphology. Thus, it mimics the actual tissue microenvironment and, subsequently, provides an opportunity to study drug metabolism and toxico-dynamics of nanotechnology-based novel formulations. The use of organoids in the evaluation of nano-drug toxicity is in its infancy. A limited number of studies conducted so far have shown good predictive value and efficiently significant data correlation with the clinical trials. In this review, we attempt to introduce organoids of the liver, lungs, brain, kidney intestine, and potential applications to evaluate toxicity caused by nanoparticles.</p>

Novel Organoid Culture System for Improved Safety Assessment of Nanomaterials

Pluripotent Stem Cells: an in Vitro Model for Nanotoxicity Assessments

Organoids: A new approach in toxicity testing of nanotherapeutics

Lung Organoids for Hazard Assessment of Nanomaterials

Establishment of a human induced pluripotent stem cell derived alveolar organoid for toxicity assessment

Organ-on-a-chip: the Next Generation Platform for Risk Assessment of Radiobiology

Testing in vitro toxicity of nanoparticles in 3D cell culture with various extracellular matrix scaffold

Application of stem cells in the study of developmental and functional toxicity of endodermal-derived organs caused by nanoparticles

In Silico Nanosafety Assessment Tools And Their Ecosystem-Level Integration Prospect

Advantages and Potential Benefits of Using Organoids in Nanotoxicology

Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review

Advances in Neural Organoid Systems and Their Application in Neurotoxicity Testing of Environmental Chemicals

Intersection of nanomaterials and organoids technology in biomedicine

A Three-Dimensional Cell Culture Platform for Long Time-Scale Observations of Bio-Nano Interactions.

Engineering Organoids-on-chips for Drug Testing and Evaluation

In vitro Toxicity Testing of Nanoparticles in 3D Cell Culture

Innovative explorations: unveiling the potential of organoids for investigating environmental pollutant exposure

Bridging toxicological properties of environmental chemicals between animals and humans using healthy organoid systems

Bioengineering Approaches for the Advanced Organoid Research

Recent Organ-on-a-chip Advances Toward Drug Toxicity Testing